Alexander Fowkes

Senior Vice President & Head-Commercial Operations at WuXi AppTec Co., Ltd.

Alexander Fowkes

Alexander Fowkes

Senior Vice President & Head-Commercial Operations at WuXi AppTec Co., Ltd.

Overview
Career Highlights

Pfizer, Inc.

RelSci Relationships

3147

Birthday

1970

Age

50

Relationships
RelSci Relationships are individuals Alexander Fowkes likely has professional access to. A relationship does not necessarily indicate a personal connection.

Executive Director & Leader of Oncology Clinical Development at Pfizer, Inc.

Relationship likelihood: Strong

Founder at WuXi AppTec Co., Ltd.

Relationship likelihood: Strong

Co-Founder at Mingma Shanghai Biotechnology Co. Ltd.

Relationship likelihood: Strong

Founding Partner at 6 Dimensions Capital

Relationship likelihood: Strong

Operating Executive, Global Healthcare Group at The Carlyle Group, Inc.

Relationship likelihood: Strong

Executive Vice President, Chief Business Officer, Head of Rsd, Head of Ltd at WuXi AppTec Co., Ltd.

Relationship likelihood: Strong

Co-Founder at WuXi AppTec Co., Ltd.

Relationship likelihood: Strong

Co-Founder at WuXi AppTec Co., Ltd.

Relationship likelihood: Strong

Executive Vice President, Chief Scientific Officer, Head of Ddsu at WuXi AppTec Co., Ltd.

Relationship likelihood: Strong

Former Associate Director-Market Assessment at Pfizer, Inc.

Relationship likelihood: Strong

Paths to Alexander Fowkes
Potential Connections via
Relationship Science
You
Alexander Fowkes
Senior Vice President & Head-Commercial Operations at WuXi AppTec Co., Ltd.
Education

The Bond University is a private not-for-profit university located in Robina, Gold Coast, Queensland, Australia.

Brisbane, Qld, AUSTRALIA

Career History
Chief Strategy Officer
Current

NextCODE Health LLC provides clinical diagnosis services. It is a sequence-based clinical diagnostics company delivering a powerful solution to genome interpretation and big data challenges. The company was founded in 2013 by Jeffrey Gulcher and Hannes Thor Smarason and is headquartered in Cambridge, MA.

Senior Vice President & Head of Commercial Operations
2012 - Current

Wuxi PharmaTech (Cayman), Inc. engages in the provision of research and development outsourcing services for the pharmaceutical, biotechnology and medical device industries. It operates through the laboratory services and manufacturing services segments. The laboratory services segment offers pharmaceutical and biotech services including discovery and medicinal chemistry, discovery biology, safety pharmacology, bioanalytical services, process research, formulation and toxicology laboratory services, as well as testing services for biologics, medical devices and combination products. The manufacturing services segment involves the production of intermediates and active pharmaceutical ingredients for or preclinical and clinical trials of small-molecule and commercial products; and biologics. The company was founded by Ge Li, Xiao Zhong Liu, Zhao Hui Zhang and Ning Zhao in 2000 and is headquartered in Shanghai, China.

Senior Vice President & Head-Commercial Operations
Current

WuXi AppTec Co., Ltd. provides an integrated pharmaceutical platform for the research, development, and production of new drugs. It operates through the following business segments: Contract research organization (CRO) services, Contract manufacturing organization (CMO)/Contract development and manufacturing organization (CDMO) business, and Others. The CRO services segment includes laboratory services in China, laboratory services in the United States, and clinical research services. The company was founded by Ge Li, Ning Zhao, Xiao Zhong Liu, Zhao Hui Zhang, and Tao Lin on December 1, 2000 and is headquartered in Shanghai, China.

Boards & Committees
Member, Board of Directors
Prior

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Alexander Fowkes. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Alexander Fowkes's profile does not indicate a business or promotional relationship of any kind between RelSci and Alexander Fowkes.